60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.070
0.00 (-0.01%)
Dec 3, 2024, 11:51 AM EST - Market open
SXTP Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$154,204
Profits / Employee
-$2,721,716
Market Cap
2.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| Molecular Templates | 62 |
| cbdMD | 52 |
| Cyclacel Pharmaceuticals | 12 |
| Entero Therapeutics | 9 |
| Dermata Therapeutics | 8 |
| ZyVersa Therapeutics | 7 |
| Virpax Pharmaceuticals | 7 |
SXTP News
- 11 days ago - 60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 18 days ago - 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - GlobeNewsWire
- 2 months ago - 60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - GlobeNewsWire
- 2 months ago - Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying - Benzinga
- 3 months ago - 60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 3 months ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results - GlobeNewsWire
- 4 months ago - 60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study - GlobeNewsWire